Commercial Credit Report for Dermapharm Holding SE

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Dermapharm Holding SE is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Dermapharm Holding SE
Lil-Dagover-Ring 7
Phone: +49 89641860p:+49 89641860	GRUENWALD, 82031 Germany	Ticker: DMPDMP

Business Summary

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.

(Source: 10-K405)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2833	Medicinal chemicals and botanical products
5122	Drugs, drug proprietaries, and druggists' sundries
8731	Commercial physical and biological research
6719	Offices of holding companies, not elsewhere classified

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chairman of the Supervisory Board	WilhelmBeier	68	8/1/2017	8/1/2017
Chairman of the Management Board, Chief Executive Officer	Hans-GeorgFeldmeier	61	8/1/2017	8/1/2017
Independent Deputy Chairman of the Supervisory Board	ErwinKern	63	1/1/2022	8/1/2017
3 additional Officers and Directors records available in full report.

Subsidiaries

Business Name	Address	City	State/Province	Country
Arkopharma SA	Zone Industrielle de Carros	Carros Cedex		France
Dermapharm AG	Lil-Dagover-Ring 7	GRUENWALD		Germany
Allergopharma GmbH & Co. KG	Hermann-Korner-Str. 52	Reinbeck	Schleswig-Holstein	Germany

Business Names

Business Name
Allergopharma GmbH & Co. KG
Arkopharma SA
Dermapharm SE
DMP

General Information

Number of Employees:	3,497	(As of 12/31/2023)
Outstanding Shares:	53,840,000	(As of 12/31/2023)
Stock Exchange:	ETR
Fax Number:	+49 8964186130

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN